[ad_1] FOCUS PERFORMANCE ANALYSIS: Spectrum Pharmaceuticals (NASDAQ: SPPI): Monitoring of profitability control, profit margin of the company recorded at -91.57% and operating margin recorded at -116.88%. The company maintained a gross margin of 74.79%. The institutional ownership of the company is 93.98% while the insider property is 10.51%. The Company …
Read More »